Impact of mixed meal tolerance test composition on measures of beta-cell function in type 2 diabetes.

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Theresa Kössler, Pavel Bobrov, Klaus Strassburger, Oliver Kuss, Oana-Patricia Zaharia, Yanislava Karusheva, Clara Möser, Kálmán Bódis, Volker Burkart, Michael Roden, Julia Szendroedi
{"title":"Impact of mixed meal tolerance test composition on measures of beta-cell function in type 2 diabetes.","authors":"Theresa Kössler,&nbsp;Pavel Bobrov,&nbsp;Klaus Strassburger,&nbsp;Oliver Kuss,&nbsp;Oana-Patricia Zaharia,&nbsp;Yanislava Karusheva,&nbsp;Clara Möser,&nbsp;Kálmán Bódis,&nbsp;Volker Burkart,&nbsp;Michael Roden,&nbsp;Julia Szendroedi","doi":"10.1186/s12986-021-00556-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Application of mixed meal tolerance tests (MMTT) to measure beta-cell function in long-term studies is limited by modification of the commercial products occurring over time. This study assessed the intra-individual reliability of MMTTs and compared the effects of liquid meals differing in macronutrient composition on the estimation of beta-cell function in type 2 diabetes (T2DM).</p><p><strong>Methods: </strong>To test the reliability of MMTTs, 10 people with T2DM (age 58 ± 11 years, body mass index 30.0 ± 4.9 kg/m<sup>2</sup>) received Boost® high Protein 20 g protein three times. For comparing different meals, another 10 persons with T2DM (58 ± 5 years, 31.9 ± 5.3 kg/m<sup>2</sup>) ingested either Boost® high Protein 20 g protein or the isocaloric Boost® high Protein 15 g protein containing 35% less protein and 18% more carbohydrates. C-peptide, insulin and glucose release were assessed from the incremental area under the concentration time curve (iAUC) and the intra- and inter-individual variation of these parameters from the coefficients of variations (CV).</p><p><strong>Results: </strong>Repetitive ingestion of one meal revealed intra-individual CVs for the iAUCs of C-peptide, insulin and glucose, which were at least 3-times lower than the inter-individual variation of these parameters (18.2%, 19.7% and 18.9% vs. 74.2%, 70.5% and 207.7%) indicating a good reliability. Ingestion of two different meals resulted in comparable intra-individual CVs of the iAUCs of C-peptide and insulin (16.9%, 20.5%).</p><p><strong>Conclusion: </strong>MMTTs provide reliable estimation of beta-cell function in people with T2DM. Furthermore, moderate differences in the protein and carbohydrate contents in a standardized liquid meal do not result in relevant changes of C-peptide and insulin responses.</p><p><strong>Trial registration: </strong>Clinicaltrials.gov, Identifier number: NCT01055093. Registered 22 January 2010 - Retrospectively registered, https://www.clinicaltrials.gov/ct2/show/study/NCT01055093.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":" ","pages":"47"},"PeriodicalIF":4.3000,"publicationDate":"2021-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12986-021-00556-1","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12986-021-00556-1","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Application of mixed meal tolerance tests (MMTT) to measure beta-cell function in long-term studies is limited by modification of the commercial products occurring over time. This study assessed the intra-individual reliability of MMTTs and compared the effects of liquid meals differing in macronutrient composition on the estimation of beta-cell function in type 2 diabetes (T2DM).

Methods: To test the reliability of MMTTs, 10 people with T2DM (age 58 ± 11 years, body mass index 30.0 ± 4.9 kg/m2) received Boost® high Protein 20 g protein three times. For comparing different meals, another 10 persons with T2DM (58 ± 5 years, 31.9 ± 5.3 kg/m2) ingested either Boost® high Protein 20 g protein or the isocaloric Boost® high Protein 15 g protein containing 35% less protein and 18% more carbohydrates. C-peptide, insulin and glucose release were assessed from the incremental area under the concentration time curve (iAUC) and the intra- and inter-individual variation of these parameters from the coefficients of variations (CV).

Results: Repetitive ingestion of one meal revealed intra-individual CVs for the iAUCs of C-peptide, insulin and glucose, which were at least 3-times lower than the inter-individual variation of these parameters (18.2%, 19.7% and 18.9% vs. 74.2%, 70.5% and 207.7%) indicating a good reliability. Ingestion of two different meals resulted in comparable intra-individual CVs of the iAUCs of C-peptide and insulin (16.9%, 20.5%).

Conclusion: MMTTs provide reliable estimation of beta-cell function in people with T2DM. Furthermore, moderate differences in the protein and carbohydrate contents in a standardized liquid meal do not result in relevant changes of C-peptide and insulin responses.

Trial registration: Clinicaltrials.gov, Identifier number: NCT01055093. Registered 22 January 2010 - Retrospectively registered, https://www.clinicaltrials.gov/ct2/show/study/NCT01055093.

Abstract Image

混合膳食耐受试验组成对2型糖尿病β细胞功能测量的影响。
背景:混合膳食耐受性试验(MMTT)在长期研究中测量β细胞功能的应用受到商业产品随时间变化的限制。本研究评估了mmtt的个体内可靠性,并比较了不同常量营养素组成的液体餐对2型糖尿病(T2DM)患者β细胞功能的影响。方法:为检验mmtt的可靠性,10例T2DM患者(年龄58±11岁,体重指数30.0±4.9 kg/m2)接受3次Boost®high Protein 20 g Protein。为了比较不同的膳食,另外10名T2DM患者(58±5岁,31.9±5.3 kg/m2)摄入Boost®高蛋白20克蛋白质或等热量Boost®高蛋白15克蛋白质,其中蛋白质减少35%,碳水化合物增加18%。通过浓度时间曲线下的增量面积(iAUC)评估c肽、胰岛素和葡萄糖的释放,通过变异系数(CV)评估这些参数的个体内和个体间变化。结果:重复进食一餐时,c肽、胰岛素和葡萄糖的iAUCs的个体内cv值比这些参数的个体间变异值(分别为18.2%、19.7%和18.9%,分别为74.2%、70.5%和207.7%)低至少3倍,具有良好的可靠性。摄入两种不同的食物导致c肽和胰岛素iAUCs的个体内cv相当(16.9%,20.5%)。结论:mmtt为T2DM患者提供了可靠的β细胞功能评估。此外,标准化液体餐中蛋白质和碳水化合物含量的适度差异不会导致c肽和胰岛素反应的相关变化。试验注册:Clinicaltrials.gov,标识号:NCT01055093。注册于2010年1月22日-追溯注册,https://www.clinicaltrials.gov/ct2/show/study/NCT01055093。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
期刊介绍: ACS Applied Electronic Materials is an interdisciplinary journal publishing original research covering all aspects of electronic materials. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrate knowledge in the areas of materials science, engineering, optics, physics, and chemistry into important applications of electronic materials. Sample research topics that span the journal's scope are inorganic, organic, ionic and polymeric materials with properties that include conducting, semiconducting, superconducting, insulating, dielectric, magnetic, optoelectronic, piezoelectric, ferroelectric and thermoelectric. Indexed/​Abstracted: Web of Science SCIE Scopus CAS INSPEC Portico
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信